James Rodriguez

Healthcare Business Reporter

Healthcare business analyst and former hospital administrator with expertise in healthcare economics, digital health transformation, and value-based care models. Spent 8 years managing operations at major health systems before becoming a specialist journalist covering healthcare investment, telemedicine adoption, and the business challenges facing healthcare providers. Known for analyzing the financial and operational impact of healthcare innovation.

AI Author, more information here

Johnson & Johnson’s $24.3 B Revenue Surge & PFA Breakthrough Propel 2024 Outlook

Johnson & Johnson’s latest fiscal results show strong growth and a focus on pulsed‑field ablation innovation, trade‑risk strategy, and quality‑driven cost control—insightful data for investors and healthcare analysts.

James Rodriguez

05/11/2025, 07:11

4 minutes to read

Philips Q3 2025 Earnings: Margins Rise, Digital Health Drives Growth

Philips Q3 earnings: modest revenue growth, rising EBITA margins and a strong push into AI‑driven imaging, cloud monitoring and digital health to meet payer value‑based models while navigating supply‑chain and cyber‑security challenges.

James Rodriguez

04/11/2025, 11:08

3 minutes to read

ResMed Shares Fall After Q1 Earnings: Dividend Boost vs. Valuation Pressure

ResMed’s Q1 earnings beat drives a 4.9% share dip, showing stronger margins but a modest dividend and mixed reimbursement outlook that may impact future growth.

James Rodriguez

03/11/2025, 09:57

5 minutes to read

How Stryker’s Q3 Surge Outpaces Peers, Boosts Margins, and Fuels Long‑Term Growth

Discover how Stryker’s Q3 earnings beat expectations, driving margin growth and tech adoption, and what that means for investors and the future of medical device innovation.

James Rodriguez

02/11/2025, 13:33

4 minutes to read

Align Technology Beats Q3 2025 Forecasts, Faces Margin Pressure & Shareholder Sell‑offs

Align Technology’s Q3 2025 earnings beat expectations, but margin erosion, a major sell‑off, and reimbursement pressures spark volatility. Discover how AI, manufacturing automation, and value‑based care could stabilize profits and reshape its dental…

James Rodriguez

02/11/2025, 09:37

4 minutes to read

Zimmer Biomet Gains FDA Breakthrough Status for Iodine‑Treated Hip Replacement, Boosting Profit and Patient Safety

Zimmer Biomet’s FDA Breakthrough Designation for its iodine‑treated hip replacement promises lower infection rates, higher reimbursements, and 4 % revenue boost in 2024.

James Rodriguez

31/10/2025, 08:31

4 minutes to read

United Therapeutics Surpasses Expectations with Record Q3 2025 Earnings and Revenue Growth

United Therapeutics Corporation reported record third-quarter 2025 results, exceeding Wall Street expectations with earnings per share of $7.16 and revenue of $799 million, driven by growth in its core product portfolio and strong operating cash flo…

James Rodriguez

30/10/2025, 09:40

3 minutes to read

Molina Healthcare Faces Legal Scrutiny Amid Market Volatility and Strategic Shifts

Molina Healthcare Inc. faces a convergence of legal, financial, and operational challenges, including a securities lawsuit, reimbursement trends, and cost-control challenges, which could impact its valuation and market position.

James Rodriguez

30/10/2025, 08:36

5 minutes to read

AstraZeneca Faces Regulatory Scrutiny Amid Market Optimism Over Financial Outlook

AstraZeneca PLC faces regulatory scrutiny over a breach of the UK’s pharmaceutical code of practice, but its strong financial outlook and favorable market sentiment remain intact, with analysts predicting continued growth and a premium valuation.

James Rodriguez

25/10/2025, 10:26

3 minutes to read

Recordati Appoints New CFO to Strengthen Financial Strategy Amid Pediatric Oncology Investments

Recordati Industria Chimica e Farmaceutica SpA has announced the appointment of Mike McClellan as Chief Financial Officer, while also repurchasing treasury shares and investing in pediatric oncology research through the Arrigo Recordati Prize, posit…

James Rodriguez

24/10/2025, 09:55

4 minutes to read

Newer articles Older articles